English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2537249      線上人數 : 224
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/63458


    題名: 以加速型腎毒血清腎炎小鼠模型研究免疫腎臟疾病之代謝體學研究
    The metabolomic study of immune kidney disease using an accelerated nephrotoxic serum nephritis mouse model
    作者: 林柏曄
    LIN, PO-YEH
    貢獻者: 藥學系博士班
    李仁愛
    關鍵詞: 腎毒血清腎炎;代謝體學;醣化終產物;圓二色光譜
    nephrotoxic serum nephritis;metabolomics;advanced glycation end products;circular dichroism
    日期: 2023-01-06
    上傳時間: 2024-01-22 14:00:21 (UTC+8)
    摘要: 本研究採用自體免疫性腎臟損傷的加速型腎毒血清(nephrotoxic serum, NTS)腎炎小鼠模型探討其損傷進程下的機轉與生物標記,根據模型進程分為正常組(Normal; W1)、IgG注射組(Control; W2)、IgG注射加NTS注射後7天(Day 7; W3)與14天(Day 14; W4)等四組。利用NMR分析非標靶性代謝體學,結果發現包含糖解作用、酮體代謝、眾多胺基酸的代謝路徑以及能量利用終點的檸檬酸循環均會隨著NTS腎炎的病程發生顯著的改變,根據L-乳酸的增加與上游胺基酸表現量的減少,推測代謝路徑的改變和瓦式效應(Warburg effect)有關,因此胺基酸的補充可能為有效改善疾病的方法。Receptor-interacting kinase 3 (RIP3)蛋白僅表現於Day 7組的腎臟組織中,顯示雖然NTS腎炎中會活化細胞程序性壞死路徑,但並非影響代謝物表現的關鍵。在標靶性代謝體學的部分,以LC-MS/MS方法測定醣化終產物Nε-(carboxyethyl)lysine (CEL)、Nε-(carboxymethyl)lysine (CML)和methylglyoxal-derived hydroimidazolone 1 (MG-H1),三者在Normal組尿液中含量分別為2.33 ± 0.28、2.77 ± 0.30與1.14 ± 0.10 μg/12 hr,在其他三組皆有1.5到2倍的含量上升,而在Normal組血清中三者的濃度分別為34.59 ± 11.56、59.83 ± 7.70與27.68 ± 3.35 ng/mL,隨著加速型NTS腎炎模型進程,三者的表現量會逐漸上升,最終在Day 14組有4.6到5.8倍之間的增加。此外,從tumor necrosis factor-α (TNF-α)和glyoxalase 1 (GLO1)的結果可知在疾病階段會活化發炎反應與乙二醛?系統,但是隨NTS腎炎進展,TNF-α會逐步上升而GLO1則逐步下降,推測免疫反應造成TNF-α增加,TNF-α會抑制GLO1,使得甲基乙二醛轉向形成醣化終產物,最終醣化終產物的堆積造成腎臟進一步的損傷。最後,本研究建立顯微鏡式圓二色光譜檢測系統,利用蛋白質經過醣化後會改變圓二色性的特性,以此檢測方法能在Day 14組發現圓二色性訊號的發生變化,代表此檢測法能成為影像醫學以及人工智能診斷的另一個應用方向。
    This study used an accelerated nephrotoxic serum (NTS) nephritis mouse model, an autoimmune kidney disease, to discover the mechanism and biomarkers of immune kidney disease. According to the progression of nephritis, four groups, including normal (Normal; W1), IgG injection (Control; W2), 7 days after NTS injection (Day 7; W3) and 14 days after NTS injection (Day 14; W4), were divided. The results of NMR-based metabolomic study showed that glycolysis, synthesis and degradation of ketone bodies, many amino acids pathway and citrate cycle were significantly affected by the progression of NTS nephritis. According to the increase of L-lactic acid and the decrease of upstream amino acids expression, the change of pathway could be related to the Warburg effect. Then, amino amino acid supplement would mitigate the progression of nephritis. In the kidney tissue, receptor-interacting kinase 3 (RIP3) was only found in the Day 7 group. The result indicated that necroptosis was activated in NTS nephritis, but it was not the key point of affecting the expression of metabolites. The advanced glycation end products (AGEs), including Nε-(carboxyethyl)lysine (CEL), Nε-(carboxymethyl)lysine (CML) and methylglyoxal-derived hydroimidazolone 1 (MG-H1), were analyzed by LC-MS/MS method. The amount of CEL, CML and MG-H1 in the urine of normal group were 2.33 ± 0.28、2.77 ± 0.30, and 1.14 ± 0.10 μg/12 hr, respectively. CEL, CML and MG-H1 in other groups were 1.5 to 2 times higher than those in normal group. In the serum, CEL, CML and MG-H1 in normal group were 34.59 ± 11.56、59.83 ± 7.70, and 27.68 ± 3.35 ng/mL. With the progression of NTS nephritis, the AGEs were gradually increased, and had 4.6 to 5.8 times increase in Day 14 group. Depends on the increase of tumor necrosis factor-α (TNF-α) and glyoxalase 1 (GLO1), inflammation and glyoxalase system were activated under disease stage. However, with the progression of NTS nephritis, TNF-α gradually increased, and GLO1 gradually decreased. Because the expression of GLO1 might be suppressed by TNF-α, methylglyoxal turned to form AGEs. The accumulation of AGEs led to more serious kidney damage. Futhermore, this study established a microscope-type circular dichroism (CD) system. Because the glycation protein leads to CD change, the system could determine the level of kidney damage. The kidney tissue of Day 14 group showed significant diffence of CD level by our CD system. The system provides another application for medical imaging and artificial intelligence diagnosis.
    描述: 博士
    指導教授:李仁愛
    委員:許秀?
    委員:李宗徽
    委員:卓爾婕
    委員:陳世銘
    委員:李仁愛
    資料類型: thesis
    顯示於類別:[藥學系] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML55檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋